about
Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligationThe glutamatergic system as a target for neuropathic pain reliefInterleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain modelAnalysis of the dorsal spinal cord synaptic architecture by combined proteome analysis and in situ hybridization.Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures.Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners.Pain inhibition by endomorphins.Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic painExpression profiling of genes modulated by minocycline in a rat model of neuropathic painSynthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cellsImmunoglobulin G4-related disease (IgG4-RD) in the orbit: mucosa-associated lymphoid tissue (MALT)-type lymphomas.Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy.Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of NeuropathyBlockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.Spontaneous cerebrospinal fluid leak at the clivus.Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic PainModulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.Dataset of botulinum toxin A influence on interleukins under neuropathy.Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model.The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction.Importance of glial activation in neuropathic pain.Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies.Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies.Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1.Characteristics, diagnosis and therapeutic strategies for IgG4-related orbital disease.The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly® device in prevention of primary headaches.Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats.Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model.IgG4-related inflammatory orbital pseudotumors - a retrospective case series.The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathyDual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics.Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain.Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain.Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain.
P50
Q24672417-C8B725D9-953C-42C3-B3DF-43EB42555185Q27006077-A5738C8D-63E2-4EE1-BF87-29DB91CAFB8DQ28571428-BA43E2A8-7BC6-4F95-83BA-EE7D3A6E11D1Q30350536-BAE8D8A7-28FA-4F02-93E6-5DAD1D7171BFQ33603235-E850BD51-019A-4895-8A1E-5E6E2F098A58Q33668659-5EC00923-2F85-4A2B-A6D2-1F4495BE1F56Q33721292-0A1894BC-230E-435B-A0A7-0C2F56726F4EQ33838465-E701DBBA-2E91-424C-859F-3047373B090CQ34020583-0E2081CA-EBA1-4BE0-B65C-F21924B122D7Q34039604-10B18959-A972-497B-9ADB-4B1962896A4EQ35107996-5D00E289-F4EE-416B-9007-DE052720139AQ35170354-3D6451AF-F291-4105-8CE2-C494B9AF42C1Q35487554-AA8C354E-E248-4E87-99E6-0D0C37951F2EQ35673953-1BB743D1-4DD5-4EE5-BC68-C266CF178637Q35674014-A8F382EA-04E1-4B91-B21C-96E7B2A9B7CAQ35795123-EEDDF15D-78DB-430F-A2BE-30896E86C806Q36453875-43854BDE-EECC-42AA-8F9D-155B400F1F5CQ36510714-B37A101E-42C8-49A9-B343-11D5225AD5F2Q36849604-FEE5D05B-47A3-40E3-A092-A8F72210258BQ37214285-0BBE265C-0165-483A-9925-74942DF8AFF5Q37438555-D4FD6E09-BD6F-42EC-8BF5-1281A571266FQ37659337-53D8AB81-C329-43F8-88D0-24A31E157E39Q37863309-2954E85B-BA7A-47FF-B472-88C49852EAF4Q38090291-252C0406-A734-4994-9915-21B46B3D6BFEQ38189559-142C8009-742B-4436-AB12-2D57EEBE7E26Q38189561-B207760F-2EB2-42A6-A105-E3DDA33EC73AQ38308504-F13CA743-A5B9-4BAD-8CD3-4CE08E455C2BQ38818204-A51FB7EF-90A2-42AB-8B4D-8794D8F60A00Q38880586-7E2096E2-F278-4D65-8A28-3F7755E8FFBBQ38980228-26F46E54-6949-4796-A324-9DC9B08AF557Q40154299-5FF526B4-C631-4C90-BB3B-0AD114FFDB76Q40366999-9F1DE662-105D-4E70-AF4A-6AAC02543CBFQ41087580-C4CE990F-CBD5-4588-9D27-3FC75FE0BA32Q41869197-497EDD5F-51E3-4385-BBA0-659579C2D6E3Q42053439-DB0D98F7-09B5-4164-B797-921FCEDD645BQ42380129-27DD1AF9-69C9-4E4E-9005-1378394569BCQ42905505-B468FD14-2C2E-43FB-8DA5-76429BD6930DQ43229604-D6669870-0BE3-4D3A-A4EC-C809D6FBB5FEQ43270943-5A874F42-5F5F-4B61-93C4-C950577945FFQ43274323-449D85DD-19B7-4CC1-A805-65843B8CA7C8
P50
description
Pools onderzoekster
@nl
hulumtuese
@sq
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Joanna Mika
@ast
Joanna Mika
@ca
Joanna Mika
@cs
Joanna Mika
@en
Joanna Mika
@es
Joanna Mika
@ga
Joanna Mika
@gl
Joanna Mika
@hr
Joanna Mika
@hsb
Joanna Mika
@it
type
label
Joanna Mika
@ast
Joanna Mika
@ca
Joanna Mika
@cs
Joanna Mika
@en
Joanna Mika
@es
Joanna Mika
@ga
Joanna Mika
@gl
Joanna Mika
@hr
Joanna Mika
@hsb
Joanna Mika
@it
altLabel
Joanna Gabriela Mika
@pl
prefLabel
Joanna Mika
@ast
Joanna Mika
@ca
Joanna Mika
@cs
Joanna Mika
@en
Joanna Mika
@es
Joanna Mika
@ga
Joanna Mika
@gl
Joanna Mika
@hr
Joanna Mika
@hsb
Joanna Mika
@it
P214
P106
P1412
P1559
Joanna Mika
@pl
P21
P214
P27
P2798
P31
P3124
P496
0000-0003-1986-7205
P734
P7859
viaf-296214895